GLAND PHARMA NEWS
Stock market update: Nifty Pharma index advances 0.66% in a weak market The Nifty Pharma index was trading 0.66 per cent up at 20325.3.
05 Jul, 2024, 09.59 AM ISTStock market update: Nifty Pharma index advances 0.14% The Nifty Pharma index closed 0.14 per cent up at 19758.25.
01 Jul, 2024, 04.51 PM ISTStock market update: Nifty Pharma index falls 0.16% The Nifty Pharma index closed 0.16 per cent down at 19514.8.
27 Jun, 2024, 04.51 PM IST- ADVERTISEMENT
Stock market update: Nifty Pharma index advances 0.07% The Nifty Pharma index closed 0.07 per cent up at 19545.35.
26 Jun, 2024, 04.00 PM ISTStock market update: Nifty Pharma index falls 0.04% The Nifty Pharma index closed 0.04 per cent down at 19521.15.
24 Jun, 2024, 04.10 PM ISTRecord block deals! Dalal Street scores Rs 23,000 crore screamer, from a Voda assist Indian stock markets hit a milestone with record block deals worth ₹23,000 crore, driven by Vodafone Group's stake sale in Indus Towers.
20 Jun, 2024, 09.05 AM ISTDelta Corp shares surge 15% on GST cut hopes Shares of Delta Corp, the sole listed company in India's casino gaming industry, saw a significant surge of nearly 15%. This increase in stock price came amidst expectations that the Goods and Services Tax (GST) Council might review the tax structur...
19 Jun, 2024, 12.24 PM ISTStocks in news: Paytm, Indus Towers, Vedanta, Cipla, Gland Pharma Domestic markets start positively with Paytm, Indus Towers, Vedanta, Cipla, Gland Pharma in focus. ZEE appoints acting CFO. Tata Technologies partners with Microsoft. Wabco to sell ZF equity. Craftsman Automation launches QIP. Fosun Pharma reduces s...
19 Jun, 2024, 07.08 AM ISTFosun is said to plan block deals to pare stake in Gland Pharma The listed arm of billionaire Guo Guangchang’s Fosun International Ltd. holds about 58% of Gland Pharma, which has a market value 303 billion rupees ($3.6 billion). It will carry out more block sales in the coming months to shore up its balance shee...
18 Jun, 2024, 03.56 PM ISTGland Pharma, Hindustan Copper among 18 stocks exited by 7 mutual funds in May16 Jun, 2024, 01.20 PM IST 7 mutual funds made complete exit from these midcap stocks13 Jun, 2024, 07.04 PM IST Stocks in news: ITC, IndiGo, Grasim, Power Grid, Nykaa, Gland Pharma Grasim Ltd, part of the Aditya Birla Group, reported 39% growth in its consolidated net profit (excluding exceptional item) at Rs 1,908 crore for the quarter ended March 2024.
23 May, 2024, 06.55 AM ISTSAIL, IRCTC among top 10 mid cap stocks that mutual funds bought in April Top 10 midcap stocks bought by mutual funds in April
17 May, 2024, 01.57 PM ISTWhat HDFC Mid Cap Opportunities mutual fund bought & sold in Jan-Mar quarter HDFC Mid-Cap Opportunities Fund's transactions in 20 stocks during January-March quarter included buying shares in Ipca Laboratories, Max Financial Services, and Adani Group owned ACC. It also added shares in Timken India, Mahindra & Mahindra Financ...
24 Apr, 2024, 11.53 AM ISTGainers & Losers: Infosys, Hindustan Zinc among top 5 stocks in spotlight on Tuesday For more such web stories click on the ET icon below
09 Apr, 2024, 05.16 PM ISTGland Pharma shares fall 6% as ex-promoter likely sells stake in block deals Shares of Gland Pharma dropped 6% to Rs 1,745 on BSE as entities related to ex-promoter Dr Ravi Penmetsa sold 5.5% equity. Large block deals of 91 lakh shares worth Rs 1,600 crore reported.
09 Apr, 2024, 10.27 AM ISTStocks in news: Gland Pharma, Axis Bank, Tata Motors, UCO Bank, Jana SFB Two entities – Nicomac Machinery and RP Advisory Services – are likely to sell upto 4.4% stake in Gland Pharma through block deals on Tuesday, according to news reports.
09 Apr, 2024, 07.13 AM ISTTwo entities likely to sell 4.4% stake in Gland Pharma via block deals: Report Nicomac Machinery and RP Advisory Services are looking at raising Rs 1,400 crore through the sale, and have set the floor price for the same at Rs 1,725/share. The floor price is at a discount of over 7% to the current market price of the stock. On...
08 Apr, 2024, 07.53 PM ISTStocks in news: Nestle India, Titan, Vodafone Idea, Wipro, Tata Steel The Board of Nestle India approved paying a royalty fee to its parent company Nestle S.A. The payment will be made at a rate of up to 5.25% of total net sales and it is payable in a staggered manner over five years.
08 Apr, 2024, 07.03 AM ISTBuy Gland Pharma, target price Rs 2240: Motilal Oswal Gland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2023.
21 Mar, 2024, 09.20 AM IST